BAH Stock Analysis: Booz Allen Hamilton Holding | NYSE
Consulting Services | NYSE, USA | Market Cap: 8.262m USD | 12M Return: -24.3% | US0995021062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 120M
EPS Trend: 93.8%
Qual. Beats: 3
Rev. Trend: 62.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Booz Allen Hamilton Holding Corporation (NYSE: BAH) is a technology company headquartered in McLean, Virginia, that provides technology solutions using artificial intelligence, cyber, and related technologies to U.S. cabinet-level departments and commercial customers domestically and internationally. Founded in 1914, the firm operates as a federal government contractor with a long history of advisory and engineering work for the public sector.
Its offerings span purpose-built AI solutions for federal clients, cyber capabilities, cloud-enabled infrastructure and data platforms, multi-modal data fusion for intelligence, surveillance, and reconnaissance, and quantum information sciences covering quantum computing, sensing, communications, and post-quantum cryptography. The company is classified under the GICS Information Technology sector, specifically the IT Consulting & Other Services sub-industry.
As a mid-cap U.S. federal contractor, Booz Allens business model is heavily weighted toward long-term government contracts, with work concentrated across defense, intelligence, and civilian agencies. This positions the firm within the broader government IT services market, where revenue is largely tied to federal budget cycles and multi-year program awards.
- DoD AI and cyber spending boost federal contract backlog
- Government shutdown threats disrupt consulting revenue and billing
- Wage inflation pressures consultant utilization and operating margins
| Net Income: 778.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 0.89 > 1.0 |
| NWC/Revenue: 10.22% < 20% (prev 11.49%; Δ -1.27% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.20b > Net Income 778.0m |
| Net Debt (3.84b) to EBITDA (1.26b): 3.06 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (120.7m) vs 12m ago -3.00% < -2% |
| Gross Margin: 44.68% > 18% (prev 54.27%; Δ -9.59% > 0.5%) |
| Asset Turnover: 150.1% > 50% (prev 166.8%; Δ -16.73% > 0%) |
| Interest Coverage Ratio: 5.70 > 6 (EBIT TTM 1.09b / Interest Expense TTM 191.0m) |
| A: 0.15 (Total Current Assets 3.04b - Total Current Liabilities 1.91b) / Total Assets 7.61b |
| B: 0.50 (Retained Earnings 3.77b / Total Assets 7.61b) |
| C: 0.15 (EBIT TTM 1.09b / Avg Total Assets 7.39b) |
| D: 0.19 (Book Value of Equity 1.20b / Total Liabilities 6.41b) |
| Altman-Z'' = 3.78 = AA |
| DSRI: 1.09 (Receivables 2.32b/2.29b, Revenue 11.1b/12.0b) |
| GMI: 1.21 (GM 54.27% / 44.68%) |
| AQI: 1.07 (AQ_t 0.55 / AQ_t-1 0.52) |
| SGI: 0.93 (Revenue 11.1b / 12.0b) |
| TATA: -0.06 (NI 778.0m - CFO 1.20b) / TA 7.61b) |
| Beneish M = -2.77 (Cap -4..+1) = A |
As of October 15, 2026, the stock is trading at USD 71.87 with a total of 1,192,453 shares traded. Over the past week, the price has changed by +4.63%, over one month by -9.15%, over three months by +13.93% and over the past year by -24.34%.
Current recommended Stop Loss: 65.50 (which is 8.9% or 2.5 ATR below the current price).
Booz Allen Hamilton Holding has received a consensus analysts rating of 3.13. Therefore, it is recommended to hold BAH.
- StrongBuy: 3
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 84.4 | 17.4% |
P/E Trailing = 10.8003
P/E Forward = 16.5289
P/S = 0.7448
P/B = 7.5703
P/EG = 1.0929
Revenue TTM = 11.1b USD
EBIT TTM = 1.09b USD
EBITDA TTM = 1.26b USD
Long Term Debt = 3.92b USD (from longTermDebt, last quarter)
Short Term Debt = 48.0m USD (from shortTermDebt, last quarter)
Debt = 4.38b USD (from shortLongTermDebtTotal, last quarter) + Leases 224.0m
Net Debt = 3.84b USD (calculated: Debt 4.38b - CCE 540.0m)
Enterprise Value = 12.1b USD (8.26b + Debt 4.38b - CCE 540.0m)
Interest Coverage Ratio = 5.70 (Ebit TTM 1.09b / Interest Expense TTM 191.0m)
EV/FCF = 10.85x (Enterprise Value 12.1b / FCF TTM 1.12b)
FCF Yield = 9.22% (FCF TTM 1.12b / Enterprise Value 12.1b)
FCF Margin = 10.06% (FCF TTM 1.12b / Revenue TTM 11.1b)
Net Margin = 7.01% (Net Income TTM 778.0m / Revenue TTM 11.1b)
Gross Margin = 44.68% ((Revenue TTM 11.1b - Cost of Revenue TTM 6.14b) / Revenue TTM)
Gross Margin QoQ = 52.29% (prev 20.88%)
Tobins Q-Ratio = 1.59 (Enterprise Value 12.1b / Total Assets 7.61b)
Interest Expense / Debt = 4.36% (Interest Expense 191.0m / Debt 4.38b)
Taxrate = 13.27% (119.0m / 897.0m)
NOPAT = 943.7m (EBIT 1.09b * (1 - 13.27%))
Current Ratio = 1.59 (Total Current Assets 3.04b / Total Current Liabilities 1.91b)
Debt / Equity = 3.65 (Debt 4.38b / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = 3.06 (Net Debt 3.84b / EBITDA 1.26b)
Debt / FCF = 3.44 (Net Debt 3.84b / FCF TTM 1.12b)
Total Stockholder Equity = 1.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.53% (Net Income 778.0m / Total Assets 7.61b)
RoE = 71.90% (Net Income TTM 778.0m / Total Stockholder Equity 1.08b)
RoCE = 21.76% (EBIT 1.09b / Capital Employed (Equity 1.08b + L.T.Debt 3.92b))
RoIC = 18.11% (NOPAT 943.7m / Invested Capital 5.21b)
WACC = 5.50% (E(8.26b)/V(12.6b) * Re(6.41%) + D(4.38b)/V(12.6b) * Rd(4.36%) * (1-Tc(0.13)))
Discount Rate = 6.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.95 | Cagr: -3.35%
[DCF] Terminal Value 77.66% ; FCFF base≈1.06b ; Y1≈1.20b ; Y5≈1.69b
[DCF] Fair Price = 180.5 (EV 25.6b - Net Debt 3.84b = Equity 21.7b / Shares 120.3m; r=8.35% [WACC [floored]]; 5y FCF grow 13.03% → 2.50% )
EPS Correlation: 93.80 | EPS CAGR: 11.56% | SUE: 1.38 | # QB: 3
Revenue Correlation: 62.13 | Revenue CAGR: 4.02% | SUE: -0.08 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.49 | Chg30d=-3.55% | Revisions=-40% | Analysts=14
EPS next Quarter (2026-12-31): EPS=1.48 | Chg30d=+0.39% | Revisions=+40% | Analysts=14
EPS current Year (2027-03-31): EPS=6.36 | Chg30d=-0.73% | Revisions=+53% | GrowthEPS=-2.3% | GrowthRev=+1.8%
EPS next Year (2028-03-31): EPS=6.73 | Chg30d=+0.11% | Revisions=-36% | GrowthEPS=+5.8% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +10% (up=15, down=12)